Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 21.77 | 17.37 |
| PEG Ratio (TTM) | -3.97 | 0.98 |
| P/S Ratio (TTM) | 0.45 | 1.37 |
| P/B Ratio (TTM) | 1.21 | 5.41 |
| P/FCF Ratio (TTM) | 4.68 | -8.37 |
| Price to 5YR AVG Earnings Ratio | 18.97 | 28.13 |
| Price to 5YR AVG FCF Ratio | 12.64 | 22.34 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.79% | 5.54% |
| ROE (TTM) | 5.63% | 9.40% |
| Net Profit Margin (TTM) | 2.02% | 5.53% |
| ROIC 5YR AVG | 8.56% | 15.16% |
Growth (82%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 22.66% | 59.89% | 20.09% |
| Revenue | 0.68% | 16.85% | 10.44% |
| Net Income | 24.07% | 60.95% | 20.34% |
| Cash Flow | -6.03% | 16.25% | 612.91% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.82 | 2.09 |
| Quick Ratio (TTM) | 1.82 | 1.21 |
| D/E Ratio (TTM) | 0.39 | 3.02 |
| Interest Coverage (TTM) | 2.56 | 2.71 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 3.25 | 3.58 |
| LTL to 5YR AVG FCF | 4.46 | 6.04 |
| Shares Outstanding Growth 5YR AVG | 0.66% | -0.22% |